Skip to main content
SpringerLink
Log in

Serum cholesterol levels in patients with cancer

Relationship with nutritional status

  • Original
  • Published:
International Journal of Clinical and Laboratory Research

Abstract

Epidemiological surveys indicate an inverse relationship between cancer occurrence and serum cholesterol. Low serum cholesterol might be either a risk factor for cancer or the effect of factors associated with cancer itself, such as biological properties of malignant cells, tumor mass, and poor nutritional status. We have measured serum cholesterol in 975 selected patients admitted to our hospital; 496 (272 males, 224 females) had solid tumors and 479 (253 males, 226 females) had non-neoplastic diseases. Serum cholesterol was positively correlated with body mass index, serum albumin, hemoglobin, and cholinesterase in both cancer and non-cancer subjects. Cholesterol was significantly lower in cancer patients than in age- and sex-matched non-cancer subjects. After adjustment for nutritional variables (analysis of covariance), the difference in cholesterol level between cancer and non-cancer subjects lost statistical significance in all but patients with tumors of the upper gastrointestinal tract. No difference was found in adjusted mean serum cholesterol between cancer patients subdivided according to the extension of the tumor was defined by the TNM system. In patients with solid tumors, serum cholesterol seems to be more related to the nutritional status than the presence and extension of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. International Task Force for Prevention of Coronary Heart Disease. Prevention of coronary heart disease: scientific back-ground and new clinical guidelines. Nutr Metab Cardiovasc Dis 1992; 2: 113.

    Google Scholar 

  2. Holme I. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence, Circulation 1990; 82: 1916.

    PubMed  CAS  Google Scholar 

  3. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a review of primary prevention trials. BMJ 1990; 301: 309.

    Article  PubMed  CAS  Google Scholar 

  4. Epstein FH. Low serum cholesterol, cancer and other noncardiovascular disorders. Atherosclerosis 1992; 94: 1.

    Article  PubMed  CAS  Google Scholar 

  5. Kritchewsky SB, Kritchewsky D. Serum cholesterol and cancer risk: an epidemiologic prespective. Annu Rev Nutr 1992; 12: 391.

    Google Scholar 

  6. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, Neaton J, Nelson J, Potter J, Rifkind B, Rossouw J, Shekelle R, Yusuf S. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992; 86: 1046.

    PubMed  CAS  Google Scholar 

  7. Meilahn EN, Ferrell RE. Naturally occurring low blood cholesterol and excess mortality. Coron Artery Dis 1993; 4: 843.

    Article  PubMed  CAS  Google Scholar 

  8. Feinlab M. On a possible inverse relation between serum cholesterol and cancer mortality. Am J Epidemiol 1981; 114: 5.

    Google Scholar 

  9. Sherwin RW, Wentworth DN, Cutler JA, Hulley SB, Kuller LH, Stamler J. Serum cholesterol levels and cancer mortality in 361 662 men screened for the Multiple Risk Factor Intervention Trial. JAMA 1987; 257:943

    Article  PubMed  CAS  Google Scholar 

  10. Kritchewsky SB, Wilkosky TC, Morris DL, Truong KL, Tyroler HA. Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer. Cancer Res 1991: 51:3198.

    Google Scholar 

  11. Winawer SJ, Flehinger BJ, Buchalter J, Herbert E, Shike M. Declining serum cholesterol levels prior to diagnosis of colon cancer: a time-trend, case-control study. J Am Med Assoc 1990: 263: 2083.

    Article  CAS  Google Scholar 

  12. Sorlie PD, Feinleib M. The serum cholesterol-cancer relationship: an analysis of time trends in the Framingham Study. J Natl Cancer Inst 1982; 69:989.

    PubMed  CAS  Google Scholar 

  13. Kagan A, McGee DL, Yano K, Rhoads GG, Nomura A. Serum cholesterol and mortality in a Japanese-American population: the Honolulu Heart Program. Am J Epidemiol 1981: 114: 11.

    PubMed  CAS  Google Scholar 

  14. Gordon T, Kannel WB, Castelli WP, Dawber TR: Lipoproteins, cardiovascular disease and death. The Frammingham Study. Arch Intern Med 1981; 141: 1128.

    Article  PubMed  CAS  Google Scholar 

  15. Rose G, Shipley MJ. Plasma lipids and mortality: a source of error. Lancet 1980; I: 523.

    Article  Google Scholar 

  16. Jacobs DR Jr. Why is blood cholesterol associated with risk of nonatherosclerotic disease death? Annu Rev Public Health 1993; 14:95.

    Article  PubMed  Google Scholar 

  17. Ettinger WH, Harris T. Causes of hypocholesterolemia. Coron Artery Dis 1993; 4:854.

    Article  PubMed  Google Scholar 

  18. Manolio TA, Ettinger WH, Tracy RP, Kuller LH, Borhani NO, Lynch LC, Fried LP. Epidemiology of low cholesterol levels in older adults. The Cardiovascular Health Study. Circulation 1993; 87:728.

    PubMed  CAS  Google Scholar 

  19. Fidanza F, ed. Nutritional status assessment—a manual for population studies. Great Britain: Chapman and Hall 1991.

    Google Scholar 

  20. Tietz NW, ed. Clinical guide to laboratory tests. Philadelphia. Saunders, 1990.

    Google Scholar 

  21. Snedecor GW, Cochran WC. Statistical methods, Iowa: Iowa State University Press, 1967.

    Google Scholar 

  22. Spiessl B, Hermanek P, Scheibe O, Wagner G. TNM-Atlas. Illustrated guide to the classification of malignant tumors. Berlin Heidelberg New York: Springer, 1985.

    Google Scholar 

  23. Alexopoulos CG, Blatsios B, Avgerinos A. Serum lipids and lipoprotein disorders in cancer patients. Cancer 1987; 60:3065.

    Article  PubMed  CAS  Google Scholar 

  24. Flaim E, Williford WO, Mullen JL, Buzby GP, Crosby LO. The relationship of serum cholesterol and vitamin A in hospitalized patients with and without cancer. Am J Clin Nutr 1986; 44:370.

    PubMed  CAS  Google Scholar 

  25. Bjelke E. Colon cancer and blood cholesterol. Lancet 1974; I:1116.

    Article  Google Scholar 

  26. Miller SR, Tarter PI, Papatestas AE, Slater G, Aufses J, Jr Serum cholesterol and human cancer. J Natl Cancer Inst 1981; 67:297.

    PubMed  CAS  Google Scholar 

  27. Nydegger UE, Butler RE. Serum lipoprotein levels in patients with cancer. Cancer Res 1972; 32:1756.

    PubMed  CAS  Google Scholar 

  28. Rose G, Blackburn H, Keys A: Colon cancer and blood cholesterol. Lancet 1974; I:181.

    Article  Google Scholar 

  29. Mendelsohn J. Principles of neoplasia. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RJ, Martin JD, Fauci AS, Root RK, eds. Harrison's principles of internal medicine. 12th edn. New York: McGraw-Hill; 1991:1576–1587.

    Google Scholar 

  30. Buchwald H. Cholesterol inhibition, cancer, and chemotherapy. Lancet 1992; 339:1154.

    Article  PubMed  CAS  Google Scholar 

  31. Ginsberg H, Gilbert HS, Gibson JC, Le NA, Brown WV. Increased low-density-lipoprotein catabolism in myeloproliferative disorders. Ann Intern Med 1982; 96:311.

    PubMed  CAS  Google Scholar 

  32. Ho YK, Smith RG, Brown MS, Goldstein JL. Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood 1978; 52:1099.

    PubMed  CAS  Google Scholar 

  33. Vitols S, Gahrton G, Bjorkholm M, Peterson C. Hypocholesterolemia in malignancy due to elevated low-density-lipoprotein receptor activity in tumor cells: evidence from patients with leukaemia. Lancet 1985; II:1150.

    Article  Google Scholar 

  34. Hinds SA, Welsh J, Stewart JM, Jack A, Soukop M, McArdle CS, Calman KC, Packard CJ, Shepherd J. Low-density-lipoprotein metabolism in mice with soft tissue tumors. Biochim Biophys Acta 1984; 795:589.

    Google Scholar 

  35. Norata G, Canti G, Ricci L, Nicolin A, Trezzi E, Catapano AL. In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour cell line in mice. Cancer Lett 1984; 25:203.

    PubMed  CAS  Google Scholar 

  36. Henriksson P, Eriksson M, Ericsson S, Rudling M, Stege R, Berglund L, Angelin B. Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet 1989; II:1178.

    Article  Google Scholar 

  37. Goldstein JL, Brown MS. The low density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 1977; 46:897.

    Article  PubMed  CAS  Google Scholar 

  38. Howson CP, Kinne D, Wynder EL. Body weight, serum cholesterol, and stage of primary breast cancer. Cancer 1986; 58:2372.

    Article  PubMed  CAS  Google Scholar 

  39. Ueyama Y, Matsuzawa Y, Yamashita S, Funahashi T, Sakai N, Nakamura T, Kubo M, Tarui S. Hypocholesterolaemic factor from gallbladder cancer cells. Lancet 1990; 336:707.

    Article  PubMed  CAS  Google Scholar 

  40. Shiroeda O, Yamaguchi N, Kawai K. Stimulation of low density lipoprotein receptor activity by conditioned medium from human cancer cell line. Cancer Res 1987; 47:4630.

    PubMed  CAS  Google Scholar 

  41. Schectman G, Sushma K, Mueller RA, Borden EC, Kissebah AH. The effect of interferon on the metabolism of LDLs. Arteriosclerosis 1992; 12:1053.

    CAS  Google Scholar 

  42. Grove RI, Mazzucco C, Allegretto N. Macrophage-derived factors increase low-density-lipoprotein uptake and receptor number in cultured human liver cells. J Lipid Res 1991; 32:1889.

    PubMed  CAS  Google Scholar 

  43. Ettinger WH, Miller LD, Albers JJ, Smith TK, Parks JS. Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: cholesterol acyltransferase in cynomolgus monkeys. J Lipid Res 1990; 31:1099.

    PubMed  CAS  Google Scholar 

  44. Beutler B, Cerami A. Cachetin and tumor necrosis factor as two sides of the same biological coin Nature 1986; 320:584.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Medicine, Hospital of Bollate, Italy

    A. M. Fiorenza, A. Branchi, A. Cardenà, M. Molgora & D. Sommariva

  2. Institute of Internal Medicine and Medical Physiopathology, University of Milan, Via Francesco Sforza, 35, I-20122, Milan, Italy

    A. Branchi & A. Rovellini

Authors
  1. A. M. Fiorenza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Branchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Cardenà
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Molgora
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Rovellini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Sommariva
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fiorenza, A.M., Branchi, A., Cardenà, A. et al. Serum cholesterol levels in patients with cancer. Int J Clin Lab Res 26, 37–42 (1996). https://doi.org/10.1007/BF02644772

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02644772

Key words

Search

Navigation